Mark Hutchins

1.0k citations
15 papers · 760 indexed · h-index 11
Topics
Lymphoma Diagnosis and Treatment (8 papers)Chronic Lymphocytic Leukemia Research (7 papers)Immunodeficiency and Autoimmune Disorders (2 papers)

In The Last Decade

Mark Hutchins

15 papers receiving 711 citations

Peers

Mark Hutchins
Comparison fields: 5 of 86
  • Pathology and Forensic Medicine 479
  • Oncology 248
  • Neurology 169
  • Genetics 153
  • Pulmonary and Respiratory Medicine 102
Replace Clara Ruíz-Ponte with:
Clara Ruíz-Ponte Spain
Ana Novokmet Canada
M.H. Skolnick United States
Richard B. Marshall United States
Kevin Zbuk Canada
A. M�ller Germany
P H Morris Jones United Kingdom
Yvan C. Bédard Canada
Richard R. Blough United States
N Mori Japan
Mark Hutchins relative to Clara Ruíz-Ponte Spain Clara Ruíz-Ponte's profile →
Citations per field
00.5×1.5×2.4×
Clara Ruíz-Ponte · 1×
Citations per year

Countries citing papers authored by Mark Hutchins

Since Specialization
Citations

This map shows the geographic impact of Mark Hutchins's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Hutchins with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Hutchins more than expected).

Fields of papers citing papers by Mark Hutchins

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Hutchins. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Hutchins. The network helps show where Mark Hutchins may publish in the future.

Co-authorship network of co-authors of Mark Hutchins

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Hutchins. A scholar is included among the top collaborators of Mark Hutchins based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Hutchins. Mark Hutchins is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
#WorkIndexed citations
1 7
2 17
3 1
4 11
5 69
6 3
7 17
8 20
9 44
10 76
11 14
12 225
13 132
14 2
15 122

About Mark Hutchins

Mark Hutchins is a scholar working on Genetics, Pathology and Forensic Medicine and Immunology, having authored 15 papers that have together received 760 indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (8 papers), Chronic Lymphocytic Leukemia Research (7 papers) and Immunodeficiency and Autoimmune Disorders (2 papers). The work is most often cited by research in Pathology and Forensic Medicine (479 citations), Genetics (153 citations) and Neurology (169 citations). Mark Hutchins has collaborated with scholars based in United States, United Kingdom and Germany. Frequent co-authors include Scot Sorensen, D F Moravec, Jamés O. Armitage, Monroe D. Dowling, David Howe, Philip J. Bierman, J A Mailliard, Dennis D. Weisenburger, Julie M. Vose and S Eto. Their work appears in journals such as Journal of Clinical Oncology, The American Journal of Medicine and BioScience.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026